Antiretroviral Therapy News

  • New Single-pill Combo Effective Against HIV-1 A new fixed-dose combination of doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/TDF) is noninferior to fixed-dose efavirenz/emtricitabine/TDF (EFV/FTC/TDF) in treatment-naive adults with HIV-1 infection, according to results from the DRIVE-AHEAD trial.
  • HIV Prevention Pill Reaching More People Who Need It More than one in nine people worldwide who might benefit from a daily pill to minimize their risk of getting HIV are now taking this medicine, a research review suggests.

Antiretroviral Therapy Perspective

  • What Doravirine Offers Patients With HIV   Dr Paul Sax describes the trials that led to the approval of doravirine, which might offer some benefits to patients who can't tolerate other NNRTIs.
  • USCA 2018 Read clinically focused news coverage of key developments from UCSA 2018.

Antiretroviral Therapy Journal Articles